Haringey Clinical Commissioning Group Governing Body meeting Thursday, 30 January 2014
Transcription
Haringey Clinical Commissioning Group Governing Body meeting Thursday, 30 January 2014
Appendix 5.4 MEETING: DATE: TITLE: LEAD DIRECTOR/ MANAGER: AUTHOR: CONTACT DETAILS: Haringey Clinical Commissioning Group Governing Body meeting Thursday, 30 January 2014 Clinical Procurement Corporate Governance and Strategic Framework 2014 Jill Shattock, Director of Commissioning Nicholas Garforth, Deputy Director Procurement & Market Management, NEL CSU Helen Boswell, Deputy Director, Clinical Procurement & Market Management, NEL CSU [email protected] SUMMARY: Haringey CCG is committed to providing high quality clinical services that meet the needs of local communities as set out in its Operating Plan agreed by the Governing Body. Within the framework of national procurement regulations it will look at all appropriate options to secure the best services for the local population. This strategic framework sets out the policy context that Haringey CCG will follow when procuring clinical services, including the application of best practice to the clinical procurement process. Where Haringey CCG proposes to award public contracts, the CCG will ensure that the procurement is conducted in accordance with the EU Procurement Directives as implemented into UK law by the Public Supply Contracts Regulations 2006 [(as amended) (SI/2006/5)] as well as taking account of relevant national and regional guidelines and the requirements of the CCG’s Constitution and the provisions of the Public Services (Social Value) Act 2012. The Governing Body is also asked to note that the Government is currently implementing the new EU Procurement Directive, which will have implications for timescales and thresholds, as well as selection and award criteria. It is therefore anticipated that a revised version of the Strategic Framework will be brought to the Governing Body later in 2014. SUPPORTING PAPERS: Clinical Procurement Corporate Governance and Strategic Framework 2014 RECOMMENDED ACTION: The Governing Body is asked to: APPROVE the Clinical Procurement Corporate Governance and Strategic Framework 2014 Objective(s) / Plans supported by this paper: Requirement for CCG to have a Clinical Procurement Corporate Governance and Strategic Framework. Audit Trail: This document has been developed from the NELCSU’s own agreed Strategic Framework document, and was first agreed as a draft template for CCGs to review and tailor to local circumstances at the NELCSU Clinical Procurement Board on 28.8.13. It was then brought in draft form to the Haringey CCG Audit Committee on 6.9.13 and 2.12.13, and then on 21.1.14, when the Committee agreed to recommend it for approval by the Governing Body. Patient & Public Involvement (PPI): n/a Equality Analysis: Equalities Impact Assessments are an integral part of the clinical procurement process (see Appendix B). Risks: The Governing Body is asked to note clause 3.2 (Conflicts of Interest) and the guidance (as yet untested in law) on the implementation of the NHS (Procurement, Patient Choice and Competition) Regulations 2013. Resource Implications: Not known.